Charles A Fox

Address:

PO Box 592322, Orlando, FL 32859

VIN:

1GCEC14097Z537842

Make:

CHEVROLET

Model:

SILVERADO C1500

Year:

2007

US Patent:

20030083610, May 1, 2003

Filed:

Jan 18, 2002

Appl. No.:

10/052075

Inventors:

Terrence McGrath - Boca Raton FL, US
Charles Fox - Fair Lawn NJ, US

International Classification:

A61M037/00

US Classification:

604/024000, 604/304000

Abstract:

Disclosed are methods and compositions for increasing tissue oxygen levels by administration of superoxygenated compositions of tissue surfaces. The methods are applicable to treatment of a wide variety of conditions including burns, bedsores, ulcers, necrosis and anaerobic infections.

US Patent:

20040166171, Aug 26, 2004

Filed:

Aug 8, 2003

Appl. No.:

10/637205

Inventors:

Terrence McGrath - Boca Raton FL, US
Charles Fox - Fair Lawn NJ, US

Assignee:

Hydron Technologies, Inc. - Pompano Beach FL

International Classification:

A61K033/00

US Classification:

424/600000

Abstract:

Disclosed are methods and compositions for increasing tissue oxygen levels by administration of superoxygenated compositions of tissue surfaces. The methods are applicable to treatment of a wide variety of conditions including burns, bedsores, ulcers, necrosis and anaerobic infections.

US Patent:

20090104237, Apr 23, 2009

Filed:

Jan 24, 2008

Appl. No.:

12/018934

Inventors:

TERRENCE S. McGRATH - Boca Raton FL, US
Charles Fox - Fair Lawn NJ, US

Assignee:

Hydrogen Technologies, Inc. - Pompano FL

International Classification:

A61K 9/00
A61K 33/00
A61K 9/12
A61P 31/04

US Classification:

424400, 424613, 424 45

Abstract:

Disclosed are methods and compositions for increasing tissue oxygen levels by administration of superoxygenated compositions of tissue surfaces. The methods are applicable to treatment of a wide variety of conditions including burns, bedsores, ulcers, necrosis and anaerobic infections.

US Patent:

45350787, Aug 13, 1985

Filed:

Apr 6, 1984

Appl. No.:

6/597531

Inventors:

Charles L. Fox - Fort Lauderdale FL
Shanta M. Modak - River Edge NJ

Assignee:

The Trustees of Columbia University in the City of New York - New York NY

International Classification:

A61K 31429
A61K 31625

US Classification:

514157

Abstract:

An antibacterial composition useful in burn therapy comprises silver sulfadiazine, sodium piperacillin and a physiologically acceptable carrier.

US Patent:

46123377, Sep 16, 1986

Filed:

May 30, 1985

Appl. No.:

6/739424

Inventors:

Charles L. Fox - Fort Lauderdale FL
Shanta M. Modak - River Edge NJ

Assignee:

The Trustees of Columbia University in the City of New York - New York NY

International Classification:

A61K 31625

US Classification:

523113

Abstract:

An infection-resistant polymeric material, such as polytetrafluoroethylene, for use on or within a human or animal body, for example, in the form of a vascular graft, can be prepared by an improved method which comprises the following sequence of steps: (a) soaking a polymeric material with a solution of an antimicrobial agent, such as sodium sulfadiazine, oxacillin dissolved in an organic solvent therefor, such as an ethanol/chloroform mixture, (b) soaking the polymeric material with an organic solvent, such as ethanol, for a metal salt; and (c) resoaking the polymeric material with the solution of the antimicrobial agent dissolved in the organic solvent therefor. The polymeric material is dried after each soaking step. Preferably, in the intermediate soaking step (b) the organic solvent contains a metal salt, such as silver nitrate, dissolved therein, so as to form in situ the metal salt of the antimicrobial agent, such as silver sulfadiazine.

US Patent:

53744322, Dec 20, 1994

Filed:

Jul 28, 1989

Appl. No.:

7/387211

Inventors:

Charles L. Fox - Fort Lauderdale FL
by Alan F. Ruf - Fort Lauderdale FL
Shanta M. Modak - River Edge NJ

Assignee:

The Trustees of Columbia University of the City of New York - New York NY

International Classification:

A61K 3338

US Classification:

424618

Abstract:

Topical compositions for use in the treatment of burns and other infection-prone wounds and of ocular infection are provided. These compositions comprise silver or a silver salt, an antibiotic selected from among aminoglycoside antibiotics and quinolone antibiotics, with the proviso that the antibiotic is not norfloxacin; and a sterile carrier, such as water or an ointment base.